-----------------------------
-----------------------------
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest
event reported):
August 26, 1997
PACIFIC PHARMACEUTICALS, INC.
------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware
----------------------
(State or other jurisdiction of incorporation)
0-14838 36-3258753
---------------------- --------------------------
(Commission File Number) (IRS Employer Identification Number)
6730 Mesa Ridge Rd.
Suite A
San Diego, California 92121
-----------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (619) 550-3900
--------------
Item 5. Other Events.
News release (the "PTM News Release") dated August 26, 1997, announcing that the
Company signed a five-year renewable distribution agreement with Steri-Oss, Inc.
(the "Steri-Oss Agreement") to exclusively distribute the Periodontal Tissue
Monitor ( the "PTM") in North America and other countries not covered by other
distribution agreements. The PTM News Release filed as Exhibit 99.59 hereto, is
hereby incorporated into this Report by reference. The Steri-Oss Agreement
filed as Exhibit 10.55 hereto, is incorporated into this Report by reference.
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.
(c) EXHIBITS. The following exhibit accompanies this Report:
Exhibit
Number Exhibit Description
------ -------------------
10.55 Exclusive Distribution Agreement dated August 12, 1997
between Pacific Pharmaceuticals, Inc. and Steri-Oss,
Inc. Portions of this Exhibit have been omitted
pursuant to a request for confidential treatment.
99.59 News release (the "PTM News Release") dated August 26,
1997, announcing that the Company signed a five-year
renewable distribution agreement with Steri-Oss, Inc.
(the "Steri-Oss Agreement") to exclusively distribute
the Periodontal Tissue Monitor ( the "PTM") in North
America and other countries not covered by other
distribution agreements.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
PACIFIC PHARMACEUTICALS, INC.
By: /s/ James Hertzog
--------------------------
James Hertzog
Date: September 29, 1997 Controller-Principal Accounting Officer
3
INDEX TO EXHIBITS
Exhibit Sequentially
Number Description of Exhibit Numbered Page
- ------ ---------------------- -------------
10.55 Exclusive Distribution Agreement dated
August 12, 1997 between Pacific
Pharmaceuticals, Inc. and Steri-Oss, Inc.
Portions of this Exhibit have been omitted
pursuant to a request for confidential treatment.
99.59 News release (the "PTM News Release") dated
August 26, 1997, announcing that the Company
signed a five-year renewable distribution
agreement with Steri-Oss, Inc. (the "Steri-Oss
Agreement") to exclusively distribute the
Periodontal Tissue Monitor ( the "PTM") in
North America and other countries not covered
by other distribution agreements.
4